Consistent with the findings of ER and TGFβRII co-expression in human ER+ breast cancer cell lines, in a clinical breast cancer series, ESR1 and TGFβRII genes were similarly co-expressed in breast cancer primary tumors and BMETs (Figure 1C). This evidence concerns the gene ESR1 and breast carcinoma.